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Abstract
Objective
Aseptic loosening (AL) is the most frequent long-term reason for revision of total knee
arthroplasty (TKA) affecting about 15–20% patients within 20 years after the surgery.
Although there is a solid body of evidence about the crucial role of inflammation in the AL
pathogenesis, scared information on inflammation signature and its time-axis in tissues
around TKA exists.
Design
The inflammation protein signatures in pseudosynovial tissues collected at revision surgery
from patients with AL (AL, n = 12) and those with no clinical/radiographic signs of AL (non-
AL, n = 9) were investigated by Proximity Extension Assay (PEA)-Immunoassay and
immunohistochemistry.
Results
AL tissues had elevated levels of TNF-family members sTNFR2, TNFSF14, sFasL, sBAFF,
cytokines/chemokines IL8, CCL2, IL1RA/IL36, sIL6R, and growth factors sAREG, CSF1,
comparing to non-AL. High interindividual variability in protein levels was evident particularly
in non-AL. Levels of sTNFR2, sBAFF, IL8, sIL6R, and MPO discriminated between AL and
non-AL and were associated with the time from index surgery, suggesting the cumulative
character of inflammatory osteolytic response to prosthetic byproducts. The source of ele-
vated inflammatory molecules was macrophages and multinucleated osteoclast-like cells in
AL and histiocytes and osteoclast-like cells in non-AL tissues, respectively. All proteins were
present in higher levels in osteoclast-like cells than in macrophages.
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Conclusions
Our study revealed a differential inflammation signature between AL and non-AL stages of
TKA. It also highlighted the unique patient’s response to TKA in non-AL stages. Further con-
firmation of our preliminary results on a larger cohort is needed. Analysis of the time-axis of
processes ongoing around TKA implantation may help to understand the mechanisms driv-
ing periprosthetic bone resorption needed for diagnostic/preventative strategies.
Introduction
Total knee arthroplasty (TKA) is one of the most effective therapies of end-stage osteoarthritis
with growing numbers of patients operated each year worldwide [1]. Currently, the total num-
ber is estimated at about 3 million cases per year. Aseptic loosening (AL) is the most common
late failure of TKA with estimated occurrence about 15–20% of patients in a 20-year time hori-
zon [2]. It is always accompanied with periprosthetic osteolysis (PPOL), which is a scientific
synonym for clinically observed bone defects. These complicate the reoperation of aseptically
loosened TKA, increase its cost, and limit survivorship of the revision TKA. The knowledge on
the pathogenesis of AL is, therefore, crucial to develop effective preventative strategies. The
molecular mechanisms underlying PPOL/AL in TKA are poorly understood. Some researchers
emphasize the role of tissue inflammation stimulated in the response to prosthetic byproducts
by innate immunity network similarly like in total hip arthroplasty (THA) [3, 4].
Contemporary biological theory links resident tissue cells [5] to maintaining local tissue
homeostasis around TKA contributing to stable and functional TKA for many years [6]. How-
ever, the continuous burden of wear particles, liberating from the articulation surfaces of TKA
during each step and migrating around bone-implant interface [7], induce release of pro-
inflammatory mediators triggering and perpetuating chronic low-grade inflammation around
TKA [8]. This chronic inflammatory condition favours secretion of a number of osteoclasto-
genic mediators, namely the receptor activator of nuclear factor kappa-B (RANK) ligand and
others, which in turn promote differentiation of macrophages into osteoclasts and multinucle-
ated giant cells, effecting bone resorption [9–11]. In addition, tissue ischemia, cell necrosis [12,
13], an increased amount of joint fluid [14], all resulting from chronic particle/ion load, and
synovitis can contribute to non-resolved inflammation and PPOL leading eventually to AL [6].
TKA also faces continual mechanical load inducing chronic stress and strain imbalances at the
bone-implant interface that could contribute to trabecular bone resorption leading potentially
to a loss of mechanical fixation [15].
Although the proteomic analysis of tissues around the TKA may lead to a better under-
standing of the complex interaction between the prosthetic device and its surrounding tissue,
the proteomic tissue signature related to PPOL/AL is poorly elucidated [16]. Only one proteo-
mic study on 29 inflammatory molecules in tissues from aseptically loosened hips has thus far
been reported [17], and no study about loosened knees is available. The current knowledge
comes from several emerging studies on serum and/or synovial fluid proteins from late PPOL/
AL [18–22]. Importantly, no information related to conditions predating PPOL/AL is
available.
In this pilot study, we attempted to examine the inflammation signature in tissues taken in
patients with TKA in AL (covering also PPOL) and non-AL stages, with special emphasis on
the TKA lifetime. The results obtained by ultra-sensitive and specific PEA Immunoassay were
confirmed by immunohistochemistry. We believe that characterisation of particular phases of
Inflammation in aseptic loosening of TKA
PLOS ONE | https://doi.org/10.1371/journal.pone.0221056 August 30, 2019 2 / 18
AL is of utmost importance for a better understanding of the underlying pathomechanisms
and development of diagnostic/preventative/therapeutic strategies for improvement of care on
patients undergoing TKA.
Material and methods
Subjects
Pseudosynovial tissues (Fig 1) were obtained from TKA patients re-operated for AL (AL,
n = 12) and non-AL patients (non-AL, n = 9) re-operated for other reasons (pain of unknown
origin, instability, fracture) than AL, with no clinical and radiographic signs of PPOL/AL at
the time of sampling. All patients were enrolled in a single tertiary center between 2009 and
2014. Stability of the TKA was examined intra-operatively by the experienced surgeon harvest-
ing periprosthetic tissues. For detailed patient characteristics, see Table 1. Infection cases were
excluded according to the previously published diagnostic algorithm [23].
Written informed consent about the use of periprosthetic tissues for the purpose of this
study was obtained from each subject prior to inclusion in the study. The Ethical Committee
for the Faculty of Medicine and Dentistry, Palacky University Olomouc and the University
Hospital Olomouc approved this study in accordance with the Helsinki Declaration (MZ ČR
VES16-31852A).
Periprosthetic tissue sample processing, protein concentration assessment
Tissue specimens (a thin surface layer of tissue covering the inner side of a joint capsule)
approximately 2x5 mm in diameter were taken from a representative and readily accessible
area of the joint capsule and evaluated macroscopically by a single surgeon. Tissue samples
were taken and processed as described below. There is already evidence that this tissue carries
relevant information on the host response to wear particles, as it is in permanent contact with
the prosthetic byproducts, signals of danger/tissue damage all dispersed in joint fluid, and it
has been as well under repetitive pressure of joint fluid until the time of the revision surgery
[24, 25].
For the preparation of tissue lysates, tissues removed from RNAlater were homogenised in
a cold RIPA buffer (Sigma Aldrich, St. Louis, USA) containing the Protease inhibitor cocktail
(Sigma Aldrich, St. Louis, USA; 1:100) using a tissue homogeniser (ULTRA-TURRAX Homo-
geniser, Sigma Aldrich) on ice. After measurement of protein concentrations with a Pierce
BCA Protein Assay Kit (Thermo Scientific, Rockford, IL), cell lysates were diluted to the same
concentrations (1mg/ml) using a cold RIPA buffer containing the Protease inhibitor cocktail
(1:100) and stored at -80˚C until use [24].
Antibody-based Proximity Extension Assay (PEA)
The protein levels of molecules associated with inflammation and osteoclastogenesis (see S1
Table) were assessed on a 92-plex Targeted Proteomics Chip (Proseek Multiplex Oncology I
kit, Olink Bioscience, Uppsala, Sweden) using 1 μl of tissue lysates as reported previously [26,
27]. For sensitivity and specificity parameters, see Assarsson et al. [28].
Histopathology and immunohistochemical analysis
For histopathological evaluation, the periprosthetic tissues consisting of only neo-synovium,
but not bone cavities, were fixed in 10% buffered formalin and embedded in paraffin [24]. One
single specimen was available per case. The paraffin sections were stained using a combination
of hematoxylin and eosin (H&E) dyes as well as immunohistochemistry for AREG, TNFR2,
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CCL2, IL8, and TRAP as previously described [29]. An immunohistoscore, antibodies and
their dilutions used in this study see S1 Text.
Fig 1. Representative samples of pseudosynovial tissues retrieved during the revision surgery. The proposed concept of events undergoing in the periprosthetic tissues
is associated with a gradual loss of local tissue homeostasis in favour of low-grade inflammatory changes with growing predominance of osteoclasts at the implant-bone
interface leading eventually to periprosthetic bone resorption (PPOL). Left panel: an early thin tissue retrieved from a stable TKA without signs of PPOL; Middle panel: a
pseudosynovial tissue covering the inner space of stable TKA without PPOL; Right panel: a well-developed pseudosynovial membrane in aseptically loosened TKA.
https://doi.org/10.1371/journal.pone.0221056.g001
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Table 1. Clinical characteristics of enrolled patients with TKA; all reoperated TKAs were cruciate retaining
implants with fixed bearing polyethylene surfaces.
Non-AL AL
Patients, N 9 12
Gender (male/female) 4/5 3/9
BMI [kg/m2] 30.1 29.9
(median, min-max) (22.9–38.9) (22.9–36.1)
Primary diagnosis
Primary OA 7 12
Posttraumatic arthritis 2 0
Age [yrs] (median, min-max)
at primary surgery& 63 (56–83) 65 (54–74)
at revision surgery§ 66 (60–83) 78 (67–84)
Time from index to revision surgery [months] 41 138
(median, min-max) (2–123) (36–202)
Reason for revision surgery:
Pain, stable TKA, firmly fixed implant 4 0
Unstable TKA, firmly fixed implant 2 0
Periprosthetic fracture, firmly fixed implant 3 0
Aseptic loosening of TKA 0 12
Type of fixation:
Cemented 9 11
Partially cemented 0 1
KSS pain before revision surgery 62.2 43.2
(median, min-max) (40–80) (35–63)
KSS function before revision surgery 60.3 47.1
(median, min-max) (20–75) (40–60)
Size of femoral bone defects:
F1 9 8
F2A 0 2
F2B 0 1
F3 0 1
Size of tibial bone defects:
T1 7 7
T2A 2 5
Polyethylene damage:
None 5 1
Small 3 3
Intermediate 0 2
Severe 1 6
Synovial fluid CRP at revision surgery [mg/L]:
<5 4 11
5–10 3 0
>10 2 1
&P = 0.374
§P = 0.006
https://doi.org/10.1371/journal.pone.0221056.t001
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Multivariate patient similarity networks
The method of network (graph) construction based on the nearest neighbour analysis [30, 31]
was applied for i) identification of the most discriminant proteins between AL and non-AL
and ii) visualisation of individual patients within similarity networks based on the similarities
in tissue protein levels. For the identification of key markers distinguishing the particular diag-
nostic subgroups, a co-occurrence network was formed. In this network, markers are vertices
and co-occurrences with their nearest neighbours are edges. As input for co-occurrence analy-
sis, the most discriminant combinations of three markers resulting from MDA (multilinear
discriminant analysis) were used. The internal structure of the patient network represents the
similarity of the immunophenotypic profiles among the patients. The nearest neighbours in
the network are linked by edges and have the highest similarity in terms of MFI expression lev-
els or the positivity/negativity of the investigated markers. In the visualised patient similarity
network, colours distinguish the particular diagnostic subgroups. Weighted network modular-
ity [32] and silhouettes were used to assess the quality of the dividing of each patient into the
particular subgroup.
Data analysis
Statistical analyses (Mann-Whitney test, Benjamini-Hochberg correction, Spearman correla-
tions) were performed using R statistical software with the Caret package (http://www.r-
project.org/; http://topepo.github.io/caret/index.html). Data analyses were performed on line-
arised expression data (2ddCq). P-values were adjusted for multiple comparisons using the
False Discovery Rate according to the Benjamini-Hochberg procedure; Pcorr value < 0.05 was
considered as significant.
Results
Tissue protein pattern associated with AL/non-AL of TKA
Ninety-two proteins were assessed in lysates from tissues sampled during AL and non-AL
reoperations in TKA patients. When comparing AL to non-AL, thirteen analytes (sTNFR2,
sAREG, IL8, CSF1, sFasL, sIL6R, MPO, TNFSF14, sBAFF, CCL2, KLK6, IL1RA, suPAR) were
upregulated in AL (Pcorr<0.05, Table 2, Fig 2) and additional twenty proteins were deregulated
(S1 Fig, S2 Table), but the differences did not reach significance after multiple comparison
adjustment. The levels of 49 proteins did not differ between subgroups (S2 Table) and the lev-
els of CA125, CA242, sCAIX, CEA, EPO, sER, KLK11, MIA, MMP3, PSA were below the
detection limit and thus excluded from further analysis.
Correlation of protein levels with the implant lifetime
When the levels of proteins in relation to the implant lifetime were assessed, higher levels of
four TNF-family members (sTNFR2, TNFSF14, sFasL, sBAFF), cytokines/chemokines (IL8,
IL1RA, sIL6R, sIL17RB, IFNγ, CCL2, CCL19), growth factors (sAREG, CSF1), and others
(TRAP, sCD69, MPO, sPECAM1, suPAR, Galectin 3, KLK6) were associated with longer time
between primary and revision surgery (P<0.05, S3 Table, Fig 2). Only chemokine CCL21 lev-
els decreased over time (P<0.05, S3 Table, S1 Fig).
In non-AL, five growth factors/angiogenic proteins (sTIE2, sVEGFR2, PGF, sHGF, sE-
selectin) correlated with the time to revision surgery (P<0.05, S3 Table, S2 Fig). In AL, only
CXCL10 levels correlated with the longer implant life (P<0.05, S3 Table, S2 Fig).
Inflammation in aseptic loosening of TKA
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Histopathological analysis of AL and non-AL tissues
Histopathological analysis of AL and non-AL tissues showed high interindividual variability
and differences in the amount and type of cellular infiltration, with the highest variability in
tissues taken during non-AL stages. Non-AL tissues showed the low intensity of synovitis,
which was milder in the early period (P1, P2, P3) and increased with longer time of implant
service (P4) (Fig 3). It was characterised by a low number of macrophages and sporadic lym-
phocytes spread in fibrous tissue below the synovial surface containing an increased amount
of synovialocytes. Vascularity was only slightly increased and occasionally present
Table 2. Levels of proteins in tissue lysates found deregulated between TKA patients with/without aseptic loosening (AL / non-AL).
Analyte Mean Linear ddCq (95% CI) FC P Pcorr
Non-AL AL
sTNFR2 8.2 (4.7–11.7) 35.7 (21.9–49.5) 4.47 8.165 × 10−5 6.70 × 10−3
sAREG 1.5 (1.0–2.1) 4.4 (3.1–5.7) 3.65 6.600 × 10−4 2.46 × 10−2
IL-8/CXCL8 4,225 (997–7,453) 23,758 (14,991–32,524) 5.68 9.390 × 10−4 2.46 × 10−2
CSF1 94.8 (55.2–134.4) 259.7 (161.5–357.9) 2.71 1.306 × 10−3 2.46 × 10−2
sFasL 26.5 (16.7–36.2) 51.4 (39.4–63.3) 2.21 1.803 × 10−3 2.46 × 10−2
sIL-6R 0.022 (0.010–0.034) 0.067 (0.043–0.090) 3.89 1.803 × 10−3 2.46 × 10−2
MPO 4.7 (2.7–6.7) 16.0 (8.9–23.1) 3.12 2.436 × 10−3 2.50 × 10−2
TNFSF14 21.0 (11.5–30.6) 69.1 (37.1–101.0) 2.84 2.436 × 10−3 2.50 × 10−2
sBAFF 8.6 (3.1–14.0) 23.9 (14.3–33.5) 3.85 3.260 × 10−3 2.97 × 10−2
CCL2/MCP1 11,257 (6,979–15,535) 24,218 (16,709–31,728) 1.68 4.300 × 10−3 3.53 × 10−2
KLK6 4.2 (2.2–6.2) 9.8 (6.6–12.9) 3.33 5.620 × 10−3 4.19 × 10−2
IL1-RA 2,489 (1,736–3,242) 4,519 (3,306–5,732) 1.68 7.253 × 10−3 4.58 × 10−2
suPAR 40.0 (26.4–53.5) 68.4 (51.5–85.3) 2.09 7.253 × 10−3 4.58 × 10−2
IFNγ 0.038 (0.027–0.050) 0.070 (0.047–0.093) 1.95 0.012 6.43 × 10−2
TRAP 1,1367 (577–1,696) 2,431 (1,606–3,256) 2.14 0.012 6.43 × 10−2
sCD30L 33.0 (20.2–45.8) 57.8 (42.1–73.6) 2.26 0.015 6.73 × 10−2
sIL17RB 0.031 (0.017–0.045) 0.062 (0.041–0.083) 2.68 0.015 6.73 × 10−2
MYD88 8.5 (4.1–12.9) 13.4 (9.9–16.9) 2.17 0.015 6.73 × 10−2
sCD69 113.9 (40.3–187.6) 240.0 (140.4–339.6) 2.78 0.023 8.87 × 10−2
IL6 272.4 (61.6–483.1) 1,242 (375–2,109) 3.89 0.023 8.87 × 10−2
sTNFR1 82.7 (36.2–129.2) 139.7 (104.4–175.1) 2.21 0.023 8.87 × 10−2
CXCL10 2,151 (-6,967–4,999) 2,909 (1,785–4,033) 2.67 0.028 9.51 × 10−2
sMICA 52.3 (19.6–85.1) 103.2 (63.4–143.0) 2.18 0.028 9.51 × 10−2
PRL 1.4 (0.7–2.2) 3.0 (1.9–4.2) 3.07 0.028 9.51 × 10−2
sBTC 249.3 (136.8–361.8) 394.7 (281.2–508.1) 2.01 0.034 0.100
sTGFA 5.3 (1.5–9.1) 8.1 (5.8–10.5) 2.20 0.034 0.100
sTNFRSF4 2.7 (1.4–3.9) 4.3 (3.0–5.6) 1.87 0.034 0.100
CXCL9 59.4 (-7.7–126.4) 125.3 (42.1–208.4) 3.35 0.041 0.100
sE selectin 0.8 (0.3–1.2) 1.7 (0.9–2.4) 3.11 0.041 0.100
Galectin 3 16.2 (8.1–24.4) 29.9 (19.4–40.5) 2.65 0.041 0.100
PRSS8 1.3 (0.6–2.0) 2.5 (1.4–3.6) 2.04 0.041 0.100
THPO 0.087 (0.047–0.100) 0.200 (0.100–0.300) 2.50 0.041 0.100
TGFB1 15.7 (10.0–21.5) 28.4 (17.9–38.8) 1.52 0.049 0.120
FC: fold change
All the data are presented as Mean Expression Level (95% CI).
Pcorr: value corrected for multiple comparisons (Benjamini-Hochberg correction)
https://doi.org/10.1371/journal.pone.0221056.t002
Inflammation in aseptic loosening of TKA
PLOS ONE | https://doi.org/10.1371/journal.pone.0221056 August 30, 2019 7 / 18
multinucleated giant cells with a low number of nuclei were found under the neo-synovial sur-
face. These cells did not contain wear particles. Wear particles were present inside of multinu-
cleated giant cells only in samples with the longest time from initial surgery (P4) together with
particle laden macrophages. H&E staining focused on the neo-synovial surface in cases, when
the synovial layer was retained. In samples without neo-synovial surface, the closest represen-
tative area was captured.
In AL tissues, high intensity of synovitis was present. The neo-synovial surface was dam-
aged or covered by a necrotic layer. Below this area, increased infiltrate of macrophages and
multinucleated giant cells with a high number of nuclei were predominantly detected. Lym-
phocytic infiltrate was minimal only in perivascular localisation. Besides particle laden macro-
phages containing particles, irregularly distributed multinucleated giant cells contained fibrilar
polarized material present in all AL cases (Fig 3).
The staining with TRAP confirmed the presence of a low number of multinucleated osteo-
clast-like giant cells with only a few nuclei in non-AL (Fig 3) with an increasing presence of
Fig 2. Protein levels of top-deregulated proteins differentially expressed in tissues from TKA patients. Protein levels of top-deregulated proteins in
pseudosynovial membrane lysates from patients with aseptic loosening (AL, yellow dots/columns) and non-aseptic loosening (non-AL, green dots/columns) stages
(left panel) and their relationship with implant lifetime (middle/right panel) are presented. The y-axis represents the normalized protein expression. The x-axis
represents the implant lifetime in months from primary TKA surgery (S). Horizontal bars indicate group means, and diagonal bars indicate the trend of protein
levels over time; error bars indicate 95% confidence interval.
https://doi.org/10.1371/journal.pone.0221056.g002
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multinucleated osteoclast-like cells with a higher number of nuclei in patients with a longer
implant lifetime (Fig 3). AL tissues were characterised by increased accumulation of giant oste-
oclast-like cells with a high number of nuclei (Fig 3). TNFR2, AREG, IL8, and CCL2 staining
was positive in both AL and non-AL tissues identifying these proteins in macrophages and
multinucleated osteoclast-like cells.
Immunohistochemical analysis of non-AL and AL tissues around TKA
Top-deregulated proteins TNFR2, AREG, IL8, CCL2 and TRAP were assessed in tissue biop-
sies using immunohistochemistry. As the distribution of positive cells was uneven, the area
with high cell positivity was taken. Overall, in AL tissues, giant osteoclast-like cells with a high
number of nuclei primarily produced the studied proteins, whereas, in non-AL, the proteins
have primarily been localised to histiocytes and osteoclast-like cells with only a few nuclei (Fig
4). All proteins were present in higher levels in multinucleated osteoclast-like cells than in
macrophages (Fig 4). When comparing AL and non-AL, trend to higher TNFR2, AREG, IL8,
and CCL2 levels was found in macrophages and multinucleated osteoclast-like cells in AL as
assessed by semiquantitative analysis. The proposed major scenarios of processes ongoing in
Fig 3. Immunohistochemical staining for TNFR2, AREG, IL8, and CCL2 in pseudosynovial membrane sections of TKA patients. Pseudosynovial
tissues were obtained from patients reoperated for aseptic loosening (AL) and non-aseptic loosening (non-AL)–representative examples. Stainings
with a non-specific isotype control antibody are shown in the upper segments of the panels. Scale bar: 50 μm.
https://doi.org/10.1371/journal.pone.0221056.g003
Inflammation in aseptic loosening of TKA
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tissues around TKA in response to wear particles liberated into the implant surroundings
shows Fig 5.
Multivariate patient similarity networks
To identify the most informative proteins distinguishing between AL and non-AL, the multi-
variate patient similarity networks based on different combinations of proteins were con-
structed and modularity values were measured. A combination with a small number of
proteins with high modularity revealed sAREG, sBAFF, IL8, sIL6R, MPO, and sTNFR2 as the
most discriminant for AL (Fig 6). AL patients with a lengthy time between primary and revi-
sion surgery formed one distinct cluster. Non-AL patients with a short time to the revision sur-
gery formed another distinct cluster (Fig 6). There were two patient’s groups (= clusters) in-
between clustering together based on a similarity in protein levels, including both AL and
non-AL: the first with a long, and the second with a short implant lifetime (Fig 6).
Discussion
Although there is a growing body of evidence about the crucial role of inflammation in AL,
only a single proteomic study in tissues of thirteen patients from aseptically failed hips investi-
gating 29 inflammatory molecules [17] exists. No information is relevant to non-AL stages and
aseptically failed TKA. We therefore attempted to investigate inflammatory molecules in tis-
sues in aseptically failed TKA as well as unique stages predating AL (non-AL) using highly
Fig 4. H&E and immunohistochemical staining for TRAP, TNFR2, AREG, IL8 and CCL2 in AL and non-AL tissues of TKA
patients. Pseudosynovial membrane sections obtained from TKA patients with the stable implant and no signs of aseptic loosening
(non-AL, P1-P4) and those with aseptic loosening (AL, P5-P8). Months (mo) indicate the time between primary and revision surgery.
H&E staining shows neo-synovial surface when present, otherwise the area below was captured. Immunohistochemical staining shows
representative areas with highest cell positivity, focused on macrophages and multinucleated osteoclast-like giant cells. Scale bar: 100 μm.
https://doi.org/10.1371/journal.pone.0221056.g004
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Fig 5. Proposed major scenarios in response to wear particles liberated into the implant surroundings. Low
particle load provokes an inflammatory response and activation of macrophages and other immune cells, which
eliminate foreign-body particles, thus enabling local tissue homeostasis (left panel) (i). Higher particle load stimulates
formation of multinucleated giant cells, differentiating in response to inflammatory/osteoclastogenic factors into
osteoclasts and accumulating at the bone-implant interface; however, in the case of (ii) particle size/shape of low
biological activity, (iii) non-susceptible individuals with protective genetic/individual parameters, or (iv) individuals
with encapsulation of wear particles into granulomas, low-grade chronic inflammation predominates over
osteoresorptive processes (middle panel). On the contrary, the bone resorption predominates over inflammation in (v)
individuals with genetic/ individual parameters predisposing to osteolysis and in (vi) those individuals with heavy
Inflammation in aseptic loosening of TKA
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sensitive PEA Immunoassay. When comparing AL to non-AL, TNF-family members
(sTNFR2, TNFSF14, sFasL, and sBAFF), cytokines/chemokines (IL8, CCL2, IL1RA/IL36,
sIL6R), and growth factors (sAREG and CSF1) were present at higher levels in AL. The most
up-regulated sTNFR2 in AL was already reported as a key molecule for osteoclast formation,
and absence of both receptor subtypes (TNFR1/TNFR2) virtually abrogated osteoclastogenesis
[33]. The importance of TNF receptors for osteoclast formation induced by TNF-α was proven
in mice deficient in these receptors [34]. Also other TNF family members (TNFSF14, FasL,
and BAFF) have been found essentially involved in osteoclastogenesis: LIGHT/TNFSF14
increased osteoclastogenesis in multiple myeloma-bone disease [35], FasL enhanced the osteo-
clasts differentiation [36] and sBAFF contributed to osteoclast differentiation [37] through
activation of an alternative NF-κB pathway [38].
IL8 and CCL2 were among the up-regulated chemokines in AL. Elevated IL8 has been
already found in aseptically failed tissues in THA [17], reaffirming its prominent role in osteo-
blast-mediated osteoclastogenesis and end-stage bone resorption [17, 39]. IL8 also directly
stimulates the differentiation of human peripheral blood mononuclear cells into bone-resorb-
ing osteoclasts [40]. Importantly, IL8 stimulates osteolysis independently of the RANKL path-
way [41]. However, IL8 connection with the macrophage proliferation and their bone invasion
is not clear and deserves future investigation. CCL2 is another key chemokine essential for the
formation of osteoclasts and foreign body giant cells [42]. Its importance is supported by the
evidence of reduced wear particle-induced osteolysis and inflammation in vivo after the deliv-
ery of mutant CCL2 protein [43, 44].
Our study also revealed the up-regulation of sIL6R, but only a slight elevation of IL6, in AL.
There is current evidence that the IL6/sIL6R system regulates RANKL-induced osteoclast for-
mation via specifically modulating phosphorylation of NF-κB, ERK, and JNK in a RANKL
concentration-dependent manner [45]. Our observation of low IL6 in AL is in line with a
particle load, where the formation of pseudosynovium with a high number of osteoclasts, executing bone resorption, is
observed at the bone-implant interface (right panel). Our theory does not exclude multiple other factors (e.g. fluid
pressure, mechanically induced bone resorption, interference of TKA body/fixation interface with the biomechanical
characteristics of the host tissue, quality of the host tissue, local and general reactivity) that may also contribute to
implant failure.
https://doi.org/10.1371/journal.pone.0221056.g005
Fig 6. Patient similarity network of the most discriminant proteins in tissue lysates from TKA patients. Patient similarity
network was constructed based on the similarity in protein levels (sAREG, sBAFF, IL8, sIL6R, MPO, and sTNFR2) in tissues
around TKA from aseptic loosening (AL, red vertices) and non-aseptic loosening (non-AL, green vertices). The number in
each vertex (= patient) indicates the implant lifetime (time from primary to revision surgery) for each particular patient in
months.
https://doi.org/10.1371/journal.pone.0221056.g006
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previous report where IL6 was not indicative of osteolysis and AL [17]. The next elevated pro-
tein was IL1RA, a competitive receptor antagonist able to block the binding of IL1α and IL1β
to IL1RI, thereby preventing IL1RI activation and inhibiting the biological action of pro-
inflammatory and pro-osteoclastogenic IL1 [46, 47]. Also CSF1, a critical growth factor for
macrophage development was shown to induce the key osteoclastogenic receptor RANK in
osteoclast precursors, thus mediating TNF-induced inflammatory osteolysis in mouse models
[48]. Regarding myeloperoxidase (MPO), the elevated levels may result from innate immune
infiltrates at the sites of inflammation and injury around TKA. However, a recent study
reported its involvement in the inhibition of osteoclast differentiation and bone resorption
[49] thus further studies are needed to clarify its role in AL.
A release of membrane-bound epidermal growth factor (EGF)-like growth factors, includ-
ing amphiregulin (AREG), HB-EGF, and TGF-α have been shown to suppress the expression
of osteoprotegerin (OPG) in osteoblasts and subsequently, potentiate osteoclast differentiation
as shown in bone metastasis [50]. Interestingly, sAREG was highly elevated in AL tissues.
There is evidence that this signalling molecule, contained in exosomes, is able to induce osteo-
clast differentiation through the activation of the EGFR pathway in pre-osteoclasts that in turn
causes increased expression of RANKL [51]. The importance of AREG was also evident from
patient similarity networks, where sAREG together with sBAFF, IL8, sIL6R, MPO, and
sTNFR2 discriminated between AL and non-AL tissues. Interestingly, four distinct patient
groups were formed based on the similarity of the protein levels: one group with only AL and
one with non-AL patients, and two in-between groups showing similarity in implant lifetime
regardless of the presence of AL. This observation furthermore supports a time-dependent
manner of inflammatory and bone-resorptive processes around TKA, thus deserving future
investigations.
Next, our proteomic analysis revealed a high variability of levels of studied proteins in non-
AL tissues. This fact suggests the patient’s unique response to TKA after implantation. This
could be explained in the context of variability in the amount of released wear particles and
their clearance by immune cells in individual patients. The levels of inflammatory/adhesion
molecules sTIE2, sVEGFR2, PGF, sHGF, and sE-selectin in non-AL tissues taken early after
reoperations were higher than those with longer prosthesis lifetime, thus supporting the
hypothesis that angiogenic/remodelling processes are activated early after surgery. A low
amount of histiocytes and occasionally present small osteoclast-like cells were detected in non-
AL tissues, which were identified as the main source of pro-osteoclastogenic molecules. Gener-
ally, low levels of pro-osteoclastogenic proteins were detected in non-AL.
In AL, the majority of elevated proteins have been associated with osteoclastogenesis and
the formation of giant multinucleated cells in previous studies. Tissues from AL showed higher
macrophage infiltration and the presence of multinucleated giant osteoclast-like cells, as
shown by staining with TRAP, a marker of osteoclasts. Interestingly, those cells accumulating
wear particles were found as the main producers of pro-osteoclastogenic proteins in this study.
The levels of elevated proteins were associated with implant lifetime, suggesting the cumulative
character of pro-osteoclastogenic response to prosthetic byproducts. In line with observation
in loosened THA [17], our data revealed an association of chemokine CXCL10 with implant
lifetime in TKA, assuming a key role of T-cells in AL. AL tissues also showed high interindivid-
ual heterogeneity in protein levels, which may result from differences in particle load and par-
ticle size/shape [52, 53], the ability of the immune system to resolve chronic inflammation and
individual genetic susceptibility to PPOL/AL [54, 55]. Moreover, the control of the “deposi-
tion” of wear particles via their disposal in tissue further from the implant [56] could also co-
influence the survivorship of TKA. Taken together, our data further confirmed the key role of
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pro-osteoclastogenic players to AL, the need to investigate the time-axis of their production, as
well as highlights the possibility to target them as shown already for CCL2 [43, 44].
This study has several limitations. In addition to the studied molecules from 92-plex tar-
geted proteomics chip, other mediators/pathways may also be involved in the development of
AL. Moreover, there is a partial overlap in terminology between AL and PPOL: AL is always
accompanied by PPOL in clinical practice, however, PPOL can be identified in some patients
without AL. Thus, we selected a unique cohort of non-AL patients with no sign of PPOL to
obtain relevant results. We believe that our preliminary study, even on a small-size patient
cohort, provides the first tracks to better understand the expression of molecules on estab-
lished time points and shows the need to analyse the time-dependent axis of processes ongoing
around TKA in future studies.
Conclusions
This first proteomic analysis of the inflammation time-axis in TKA tissues revealed the cumu-
lative nature of the inflammatory response to prosthetic byproducts. The majority of proteins
elevated in AL were associated with osteoclastogenesis and formation of giant multinucleated
cells, whereas many of them were not linked to AL previously. Levels of inflammatory mole-
cules were associated with the time elapsed from the index surgery, thus suggesting the cumu-
lative character of tissue changes induced and perpetuated in response to prosthetic
byproducts. The understanding of processes predating AL and better characterisation of the
time-axis of inflammatory and osteoresorptive processes may help to propose effective preven-
tative/therapeutic strategies contributing to the prolongation of the prosthesis lifetime. The
results of our preliminary study need to be confirmed in a larger patient cohort.
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